Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Hrv And Pulse Diagnosis

Research Leaders

10 sponsors active, led by Taipei Veterans General Hospital, Taiwan

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown3
Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT07180017Completed

A Survey of Turkish Pediatric Physical Therapists

NCT06761248Not ApplicableNot Yet Recruiting

Comparing Fluorescent Starch Nanoparticles Rinse with ICDAS for Early Caries Detection in Children

NCT05862597UnknownPrimary

Post COVID-19 Syndrome Study With Questionnaires and Instruments Measurements

NCT04799756UnknownPrimary

Pulse Diagnosis of Traditional Chinese Medicine

NCT04164186UnknownPrimary

Fully Automated Pipeline for the Detection and Segmentation of Non-Small Cell Lung Cancer (NSCLC) on CT Images

Showing all 5 trials

Research Network

Common Treatments

  • Hrv And Pulse Diagnosis1
  • Fluorescent Starch Nanoparticles Caries Detection Rinse1
  • Automatic Detection And Segmentation Of Nsclc Tumors1

Active Sponsors

  • Taipei Veterans General Hospital, Taiwan2
  • Maastricht University1
  • Kahramanmaras Sutcu Imam University1
  • Cairo University1
  • National Yang Ming Chiao Tung University1

Top Investigators

Related Conditions

  • Cerebral Palsy Cp1
  • Dental Caries1
  • Fluorescence1
  • Diagnostic Accuracy1
  • Pediatric Physiotherapy1

Activity Timeline